NEW YORK, Oct.16 (GenomeWeb News) - Illumina today posted a dramatic increase in third-quarter revenues atop fallen R&D expenditures and narrowed net loss.
Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.
Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.
